scispace - formally typeset
B

Barbara V. Howard

Researcher at MedStar Health

Publications -  622
Citations -  68693

Barbara V. Howard is an academic researcher from MedStar Health. The author has contributed to research in topics: Population & Diabetes mellitus. The author has an hindex of 112, co-authored 593 publications receiving 63071 citations. Previous affiliations of Barbara V. Howard include Memorial Hospital of South Bend & Georgetown University.

Papers
More filters
Journal ArticleDOI

Relations of Left Ventricular Mass to Fat-Free and Adipose Body Mass The Strong Heart Study

TL;DR: LV mass is more strongly related to FFM than to adipose mass, waist/hip ratio, body mass index, or height-based surrogates for lean body weight; LV mass/FFM criteria may increase sensitivity to detect LV hypertrophy.
Journal ArticleDOI

Relations of central and brachial blood pressure to left ventricular hypertrophy and geometry: the Strong Heart Study.

TL;DR: Left ventricular hypertrophy is more strongly related to systolic pressure than to pulse pressure, and central pressures are more stronglyrelated than brachial pressures to concentric left ventricular geometry, which suggest that absolute (systolic) pressure is more important in stimulatingleft ventricularhypertrophy and remodeling, whereas pulsatile stress (pulse pressure) is moreImportant in causing vascular hyperTrophy and atherosclerosis.
Journal ArticleDOI

Coronary Heart Disease Prevalence and Its Relation to Risk Factors in American Indians The Strong Heart Study

TL;DR: Findings from the initial Strong Heart Study examination emphasize the importance of diabetes and its associated variables as risk factors for CHD in Native American populations.
Journal ArticleDOI

Effect of statins alone versus statins plus ezetimibe on carotid atherosclerosis in type 2 diabetes: the SANDS (Stop Atherosclerosis in Native Diabetics Study) trial.

TL;DR: In this article, a secondary analysis from the SANDS (Stop Atherosclerosis in Native Diabetics Study) trial examined the effects of lowering low-density lipoprotein cholesterol with statins alone versus statins plus ezetimibe on common carotid artery intima-media thickness (CIMT) in patients with type 2 diabetes and no prior cardiovascular event.